News

FDA can grant final approval of YUTREPIA after blocking regulatory exclusivity expires on May 23, 2025 ...
Investors are reacting to the news that Liquidia now has a clear runway for Yutrepia’s market entry, which could occur when United Therapeutics’ exclusivity expires. This development is seen as a ...
Secretary of Health and Human Services Robert F. Kennedy Jr. falsely claimed that the MMR vaccine contains “aborted fetus ...
Thursday was a roller coaster ride for Michael Waltz, who was removed as national security adviser and later named to be U.N.
Manchester United’s U18 side hosted Stoke City U18s at Carrington on Friday night.A rare evening match for Adam Lawrence’s ...
Vice President Vance appeared briefly at a May 1 $1 million-per-person fundraiser hosted at Worth Avenue's Le Bilboquet ...
This year’s slogan of the European Immunization Week 2025, “Humanly Possible,” once again underscores the importance of early ...
The Boston Avenue United Methodist Church in Tulsa held an Interfaith Prayer Service to celebrate National Day of Prayer.
Lexeo Therapeutics, Inc.’s LXEO share price has surged by 5.20%, which has investors questioning if this is right time to ...
According to a draft invitation shared by a Daily Mail reporter, Vice President JD Vance will be at a $1 million-per-person fundraiser in Palm Beach.
United Therapeutics’ UTHR first-quarter 2025 earnings of $6.63 per share beat the Zacks Consensus Estimate of $6.29. The ...
Amicus licenses exclusive U.S. rights to commercialize DMX-200 for the treatment DMX-200 is in a pivotal Phase 3 trial for ...